牛牛AI助理已提取核心讯息中国生物制药宣布,将于2025年8月18日(星期一)召开董事会会议,主要议程包括审议及批准截至2025年6月30日止六个月期间之未经审核中期业绩,同时将考虑派发中期股息事宜。公司董事会现由六位执行董事及五位独立非执行董事组成,执行董事包括谢其润女士、谢炳先生、郑翔玲女士、谢承润先生、谢炘先生及田舟山先生;独立非执行董事包括陆正飞先生、李大魁先生、鲁红女士、张鲁夫先生及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.